Menu

• Ask a Health Expert about BRONCHIAL OBSTRUCTION
• Post Your Side Effect related to BRONCHIAL OBSTRUCTION
• BRONCHIAL OBSTRUCTION and FDA Warnings
• BRONCHIAL OBSTRUCTION in Patients Wiki
• Report BRONCHIAL OBSTRUCTION in Drug Side Effect Survey

BRONCHIAL OBSTRUCTION side effect

What is BRONCHIAL OBSTRUCTION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Alna Side Effects Report #5564046-2
Consumer or non-health professional from reported ALNA OCAS problem on Dec 12, 2007. Male patient, weighting 224.9 lb, was diagnosed with micturition disorder, fibromyalgia, intervertebral disc disorder, dyspepsia and was treated with ALNA OCAS. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, dyspnoea, nasal congestion, . ALNA OCAS dosage: unknown. During the same period patient was treated with VOLTAREN, SOGOON, MYRRHINIL, SALVYSAT, DICLAC, ENZYM. Patient recovered.

Propofol Side Effects Report #5504749-9
PROPOFOL problem was reported by a Physician from NORWAY on Oct 24, 2007. Female patient, 52 years of age, was diagnosed with anaesthesia and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, . PROPOFOL dosage: unknown. During the same period patient was treated with REMIFENTANIL, ACETAMINOPHEN, VOLTAREN, OXYCONTIN. Patient recovered.

Lamisil Side Effects Report #5524826-6
Physician from RUSSIAN FEDERATION reported LAMISIL problem on Nov 16, 2007. Female patient, 59 years of age, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, dyspnoea, . LAMISIL dosage: unknown. Patient recovered.

Vepesid Side Effects Report #5464215-6
VEPESID problem was reported by a Health Professional from GERMANY on Sept 18, 2007. Female patient, 60 years of age, weighting 83.78 lb, was diagnosed with bronchial carcinoma and was treated with VEPESID. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, dyspnoea, erythema, feeling hot, oxygen saturation decreased, sinus tachycardia, . VEPESID dosage: unknown. Patient recovered.


Synagis Side Effects Report #5378440-6
Physician from FRANCE reported SYNAGIS problem on June 20, 2007. Female patient was diagnosed with antiviral prophylaxis and was treated with SYNAGIS. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, bronchiolitis, bronchitis, cardiopulmonary failure, convulsion, corona virus infection, hyperthermia, lung disorder, pyelonephritis acute, . SYNAGIS dosage: unknown. Patient was hospitalized. Patient recovered.

Synagis Side Effects Report #5378440-6
SYNAGIS problem was reported by a Physician from FRANCE on June 20, 2007. Female patient was diagnosed with antiviral prophylaxis and was treated with SYNAGIS. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, bronchiolitis, bronchitis, cardiopulmonary failure, convulsion, corona virus infection, hyperthermia, lung disorder, pyelonephritis acute, . SYNAGIS dosage: unknown. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #5776618-0
Physician from COLOMBIA reported NAGLAZYME problem on June 02, 2008. Male patient, child 12 years of age, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis vi and was treated with NAGLAZYME. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, cardiac failure, cardio-respiratory arrest, cardiomyopathy, disease progression, mucopolysaccharidosis vi, multi-organ failure, pulmonary hypertension, renal failure, . NAGLAZYME dosage: 20 MG; QW; IV. During the same period patient was treated with ALDACTONE, FUROSEMIDE, SILDENAFIL, CARVEDILOL. Patient was hospitalized. Patient died on 04/22/2008.

Myozyme Side Effects Report #5753890-4
MYOZYME problem was reported by a Physician from CROATIA (local name: Hrvatska) on May 16, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea, . MYOZYME dosage: 200 MG, Q2W; INTRAVENOUS. Patient was hospitalized. Patient recovered.

Diovan Side Effects Report #5282898-0
Consumer or non-health professional from reported DIOVAN problem on Mar 19, 2007. Male patient was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, cough, surgery, . DIOVAN dosage: 80MG. During the same period patient was treated with CRESTOR, ANTICOAGULANTS. Patient was hospitalized. Patient recovered.


Deroxat Side Effects Report #5296235-9
DEROXAT problem was reported by a Consumer or non-health professional from FRANCE on Apr 04, 2007. Male patient, 86 years of age, weighting 154.3 lb, was diagnosed with computerised tomogram and was treated with DEROXAT. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, infection, inflammation, purpura, skin oedema, toxic skin eruption, . DEROXAT dosage: unknown. During the same period patient was treated with OMNIPAQUE, TIENAM, VANCOMYCIN, IOBITRIDOL. Patient was hospitalized. Patient recovered.

Augmentin Side Effects Report #5304590-6
Consumer or non-health professional from FRANCE reported AUGMENTIN problem on Apr 18, 2007. Male patient, 68 years of age, was diagnosed with infection, infection parasitic, nausea and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, conjunctival disorder, conjunctival oedema, corneal perforation, disturbance in attention, dysphagia, ear pain, eye infection bacterial, eye operation, . AUGMENTIN dosage: unknown. During the same period patient was treated with TRIFLUCAN, ETHYOL, CIPROFLOXACIN, PERFALGAN, PRIMPERAN, SEROPRAM. Patient was hospitalized. Patient recovered.

Sutent Side Effects Report #5311893-8
SUTENT problem was reported by a Pharmacist from UNITED STATES on Apr 26, 2007. Male patient, 64 years of age, weighting 200.0 lb, was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, cardiac failure congestive, cardiomyopathy, metastatic renal cell carcinoma, . SUTENT dosage: unknown. Patient was hospitalized. Patient recovered.

Spiriva Side Effects Report #5333585-1
Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Jan 02, 2007. Female patient was diagnosed with chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, dyspnoea, . SPIRIVA dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, POTASSIUM, AZMACORT, LENOXIN, ZOCOR, TYLENOL. Patient recovered.

Bevacizumab Side Effects Report #5255886-8
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Feb 15, 2007. Male patient, 63 years of age, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, chronic obstructive pulmonary disease, condition aggravated, diverticular perforation, lung infection pseudomonal, lung neoplasm, pulmonary thrombosis, respiratory distress, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, VANCOMYCIN HYDROCHLORIDE, FORTAZ, FLAGYL, PROTONIX, NORVASC, PULMICORT, FOLIC ACID. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5279569-3
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 12, 2007. Male patient, 63 years of age, was diagnosed with neoplasm malignant and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, chronic obstructive pulmonary disease, condition aggravated, diverticular perforation, lung infection pseudomonal, lung neoplasm, pulmonary thrombosis, respiratory distress, . BEVACIZUMAB dosage: 15 MG/MKG, Q3W, INTRAVENOUS. During the same period patient was treated with ALIMTA, LEVOTHYROXINE, VANCOMYCIN HYDROCHLORIDE, FORTAZ, FLAGYL, PROTONIX, NORVASC, PULMICORT. Patient was hospitalized. Patient recovered.

Penicillamine Side Effects Report #5283998-1
PENICILLAMINE problem was reported by a Physician from JAPAN on Mar 23, 2007. Female patient, 57 years of age, was diagnosed with arthritis and was treated with PENICILLAMINE. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, lymphocytic infiltration, obliterative bronchiolitis, . PENICILLAMINE dosage: 200MG PO QD. Patient was hospitalized. Patient recovered.

Aleve Side Effects Report #5658369-6
Consumer or non-health professional from UNITED STATES reported ALEVE problem on Feb 06, 2007. Female patient, 58 years of age, was diagnosed with arthralgia and was treated with ALEVE. After drug was administered, patient experienced the following problems/side effects: asthma, bronchial obstruction, increased upper airway secretion, wheezing, . ALEVE dosage: TOTAL DAILY DOSE: 440 MG UNIT DOSE: 220 MG. Patient recovered.

Tarceva Side Effects Report #5670188-3
TARCEVA problem was reported by a Physician from NETHERLANDS on Feb 27, 2008. Female patient, 62 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: alopecia, bronchial obstruction, cerebellar haemorrhage, cerebral haemorrhage, cerebral ischaemia, haemoptysis, malignant neoplasm progression, metastases to central nervous system, non-small cell lung cancer metastatic, . TARCEVA dosage: 150 MG, QD, ORAL. During the same period patient was treated with PREDNISONE, TEMAZEPAM. Patient was hospitalized. Patient died on 01/17/2008.

Temodal Side Effects Report #5633182-4
Consumer or non-health professional from FRANCE reported TEMODAL problem on Feb 11, 2008. Female patient, 74 years of age, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bronchial obstruction, cholestasis, constipation, cytolytic hepatitis, ill-defined disorder, . TEMODAL dosage: 240 MG;QD;PO. During the same period patient was treated with ACETAMINOPHEN, NOROXIN, OMEPRAZOLE, AMOXICILLIN, PROZAC, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.


Prograf Side Effects Report #5605739-8
PROGRAF problem was reported by a Physician from JAPAN on Jan 07, 2008. Female patient, child 8 years of age, weighting 42.77 lb, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: atelectasis, bronchial obstruction, bronchopneumonia, epstein-barr virus infection, inflammation, leiomyosarcoma, metastases to lung, metastasis, pneumococcal infection, . PROGRAF dosage: 4 MG, BID, ORAL, 2.5 MG, BID, ORAL, 2 MG, BID, ORAL, 1 MG, BID, ORAL, 0.5 MG, BID, ORAL. During the same period patient was treated with CELLCEPT. Patient was hospitalized. Patient recovered.

Chantix Side Effects Report #5567643-3
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Dec 07, 2007. Female patient, weighting 125.0 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: abasia, bronchial obstruction, dyspnoea, . CHANTIX dosage: unknown. During the same period patient was treated with LORATADINE. Patient recovered.

Alimta Side Effects Report #5489398-3
ALIMTA problem was reported by a Physician from UNITED STATES on Oct 09, 2007. Female patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: atelectasis, bronchial obstruction, dyspnoea, hypoxia, malignant neoplasm progression, pleural effusion, . ALIMTA dosage: unknown. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5767378-8
Physician from FRANCE reported ARIXTRA problem on June 02, 2008. Male patient, 76 years of age, weighting 136.7 lb, was diagnosed with prophylaxis, oliguria and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, bronchial obstruction, haemoptysis, . ARIXTRA dosage: 2.5MG PER DAY. During the same period patient was treated with UMULINE, NEXIUM, LASILIX, DOBUTREX. Patient was hospitalized. Patient recovered.

Elaprase Side Effects Report #5748529-8
ELAPRASE problem was reported by a Physician from UNITED STATES on May 12, 2008. Male patient, 27 years of age, weighting 80.03 lb, was diagnosed with mucopolysaccharidosis ii and was treated with ELAPRASE. After drug was administered, patient experienced the following problems/side effects: acidosis, bronchial obstruction, grand mal convulsion, hypercapnia, obstructive airways disorder, respiratory failure, . ELAPRASE dosage: 0.5 MG/KG, 1X/WEEK, IV DRIP. During the same period patient was treated with ZANTAC, FLOVENT, DILANTIN, ALPRAZOLAM, COMBIVENT, ALBUTEROL, DOCUSATE, PREDNISONE. Patient was hospitalized. Patient died on 01/23/2008.

Augmentin Side Effects Report #5708168-1
Consumer or non-health professional from FRANCE reported AUGMENTIN problem on Apr 04, 2008. Male patient, 55 years of age, was diagnosed with cancer pain and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: bronchial fistula, bronchial obstruction, haemoptysis, hypersensitivity, pain, prurigo, pulmonary necrosis, tachycardia, . AUGMENTIN dosage: unknown. During the same period patient was treated with DAFALGAN, PERFALGAN, CONTRAMAL, ACTISKENAN, LOVENOX, INIPOMP, KARDEGIC, SECALIP. Patient was hospitalized. Patient died on 06/27/2007.

Vidaza Side Effects Report #5710716-2
VIDAZA problem was reported by a Physician from FRANCE on Mar 31, 2008. Male patient, 72 years of age, weighting 178.6 lb, was diagnosed with myelodysplastic syndrome, neutropenia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: apnoea, bronchial obstruction, interstitial lung disease, pulmonary fibrosis, pulmonary function test abnormal, . VIDAZA dosage: (75 MG/M2,DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with GRANOCYTE, DEPAKENE, VESANOID, SECTRAL, ALLOPURINOL, PANTOPRAZOLE, RENITEC, FORLAX. Patient was hospitalized. Patient recovered.

Irbesartan Side Effects Report #5712999-1
Health Professional from FRANCE reported IRBESARTAN problem on Apr 16, 2008. Female patient, 95 years of age, was diagnosed with hypertension, confusional state, sleep disorder, myocardial ischaemia and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: bradycardia, bronchial obstruction, depressed level of consciousness, erysipelas, hypothermia, intestinal obstruction, sinus bradycardia, somnolence, . IRBESARTAN dosage: unknown. During the same period patient was treated with RISPERDAL, SERESTA, CARDENSIEL, NITRODERM, ESIDRIX, ADANCOR, ACTISKENAN. Patient was hospitalized. Patient recovered.

Ethyol Side Effects Report #5352383-6
ETHYOL problem was reported by a Consumer or non-health professional from FRANCE on May 25, 2007. Male patient, 68 years of age, was diagnosed with prophylaxis, infection, nausea, vomiting and was treated with ETHYOL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, bronchial obstruction, corneal perforation, dermatitis exfoliative, disturbance in attention, dysphagia, erythema, fall, haemodynamic instability, . ETHYOL dosage: 340 MG, 3 IN 1 WK, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CIPROFLOXACIN, AUGMENTIN, FLUCONAZOLE, ACETAMINOPHEN, PRIMPERAN, CITALOPRAM HYDROBROMIDE. Patient was hospitalized and became disabled. Patient recovered.

Carboplatin Side Effects Report #5369943-9
Consumer or non-health professional from GERMANY reported CARBOPLATIN problem on June 05, 2007. Female patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: asphyxia, bronchial obstruction, cardiac arrest, cardiovascular disorder, multi-organ failure, pulse absent, . CARBOPLATIN dosage: (450 MG); INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with VINORELBINE. Patient died.

Pemetrexed Side Effects Report #5318200-5
PEMETREXED problem was reported by a Physician from INDIA on Apr 27, 2007. Male patient, 42 years of age, weighting 70.55 lb, was diagnosed with prophylaxis of nausea and vomiting, prophylaxis against gastrointestinal ulcer, antiemetic supportive care, dental disorder prophylaxis and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bronchial obstruction, lung infection, . PEMETREXED dosage: 595 MG, ONCE EVERY 21 DAYS. During the same period patient was treated with ATIVAN, GRANISETRON, PERINORM, RANTAC, TANTUM, PANTOPRAZOLE, ONDANSETRON, CANDID B. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5334980-7
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on May 25, 2007. Male patient, 42 years of age, weighting 70.55 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bronchial obstruction, cardiac arrest, lung infection, . CARBOPLATIN dosage: unknown. During the same period patient was treated with PEMETREXED DI, FOLIC ACID, VITAMIN B, DEXAMETHASONE, ATIVAN, GRANISETRON, PERINORM, RANTAC. Patient was hospitalized. Patient died on 05/12/2007.

Carboplatin Side Effects Report #5338637-8
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Male patient, 42 years of age, weighting 70.55 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bronchial obstruction, cardiac arrest, cardio-respiratory arrest, lung injury, . CARBOPLATIN dosage: unknown. During the same period patient was treated with PEMETREXED DI, FOLIC ACID, VITAMIN B, DEXAMETHASONE, ATIVAN, GRANISETRON, PERINORM, RANTAC. Patient was hospitalized. Patient died on 05/12/2007.

Rocuronium Side Effects Report #5339492-2
Consumer or non-health professional from FINLAND reported ROCURONIUM BROMIDE problem on May 21, 2007. Female patient, 26 years of age, was treated with ROCURONIUM BROMIDE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, bronchial obstruction, flushing, hypotension, oxygen saturation decreased, shock, urticaria, . ROCURONIUM BROMIDE dosage: 35 MG ONCE INTRAVENOUS (NOS). During the same period patient was treated with ROCURONIUM BROMIDE, SEVOFLURANE, THIOPENTAL, FENTANYL, PROPOFOL, PARACETAMOL, MIDAZOLAM HYDROCHLORIDE, INSULIN ASPART. Patient was hospitalized. Patient recovered.

Citalopram Side Effects Report #5306048-7
CITALOPRAM HYDROBROMIDE problem was reported by a Health Professional from FRANCE on Apr 03, 2007. Male patient, 53 years of age, was diagnosed with cerebrovascular disorder and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: brain herniation, bronchial obstruction, coma, hypertonia, hypoxia, international normalised ratio increased, intracranial pressure increased, somnolence, subdural haematoma, . CITALOPRAM HYDROBROMIDE dosage: 10 MG QD PO. During the same period patient was treated with PREVISCAN, NEURONTIN. Patient died on 01/17/2007.

Depakene Side Effects Report #5256894-3
Health Professional from FRANCE reported DEPAKENE problem on Feb 26, 2007. Male patient, 30 years of age, was diagnosed with postoperative care and was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: aggression, bronchial obstruction, cyanosis, granulocytosis, hyperhidrosis, hyperthermia, open wound, tachycardia, . DEPAKENE dosage: unknown. During the same period patient was treated with TRAMADOL, LOXAPINE SUCCINATE, CLOZAPINE, RISPERDAL, CLAVULIN, NORSET, TRIHEXYPHENIDYL HYDROCHLORIDE, HYOSCINE HYT. Patient was hospitalized. Patient died on 11/22/2006.

Rebif Side Effects Report #5274505-8
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2007. Female patient, 34 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: atelectasis, bronchial obstruction, malnutrition, respiratory failure, . REBIF dosage: unknown. Patient was hospitalized. Patient died on 03/07/2007.

Citalopram Side Effects Report #5284860-0
Health Professional from DENMARK reported CITALOPRAM HYDROBROMIDE problem on Mar 13, 2007. Male patient, 53 years of age, was diagnosed with cerebrovascular disorder and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: brain herniation, bronchial obstruction, hypertonia, international normalised ratio increased, prothrombin time ratio increased, subdural haematoma, tachypnoea, . CITALOPRAM HYDROBROMIDE dosage: 10 MG QD PO. During the same period patient was treated with PREVISCAN, NEURONTIN. Patient died.

Diclofenac Side Effects Report #5424366-9
DICLOFENAC problem was reported by a Consumer or non-health professional from GERMANY on July 06, 2007. Male patient, 39 years of age, was diagnosed with nasopharyngitis and was treated with DICLOFENAC. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, aspergillosis, bronchial obstruction, bronchopulmonary aspergillosis, disseminated intravascular coagulation, gangrene, ischaemic hepatitis, lymphocyte percentage decreased, . DICLOFENAC dosage: SINGLE INJECTION (75 MG, 1 IN 1 ONCE), INTRAMUSCULAR. Patient was hospitalized. Patient died.

Seretide Side Effects Report #5734894-4
Consumer or non-health professional from FRANCE reported SERETIDE problem on May 06, 2008. Female patient, 69 years of age, was diagnosed with asthma, pain and was treated with SERETIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, alveolitis, bronchial obstruction, hypoxia, lung disorder, pain, painful respiration, phlebitis, pleural effusion, . SERETIDE dosage: unknown. During the same period patient was treated with TAXOTERE, SOLUPRED, NEXIUM, DIANTALVIC, DURAGESIC. Patient was hospitalized. Patient recovered.

Ethyol Side Effects Report #5328637-6
ETHYOL problem was reported by a Consumer or non-health professional from FRANCE on May 01, 2007. Male patient, 68 years of age, was diagnosed with prophylaxis, infection, nausea, vomiting and was treated with ETHYOL. After drug was administered, patient experienced the following problems/side effects: adhesion, agranulocytosis, bronchial obstruction, catheter site infection, corneal perforation, depressed level of consciousness, dermatitis exfoliative, dysphagia, eyelid disorder, . ETHYOL dosage: 340 MG, 3 IN 1 WK, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, AUGMENTIN, FLUCONAZOLE, PERFALGAN, PRIMPERAN, CITALOPRAM HYDROBROMIDE. Patient was hospitalized and became disabled. Patient recovered.

Cetuximab Side Effects Report #5287822-2
Health Professional from UNITED STATES reported CETUXIMAB problem on Apr 03, 2007. Female patient, weighting 163.4 lb, was diagnosed with breast cancer metastatic and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, asthma, bronchial obstruction, bronchospasm, cardiac failure, chronic obstructive pulmonary disease, condition aggravated, diastolic dysfunction, electrocardiogram st segment elevation, . CETUXIMAB dosage: 250 MG/M2 IV BOLUS WEEKLY IV 040. During the same period patient was treated with CARBOPLATIN, PULMICORT. Patient was hospitalized. Patient recovered.

Alkeran Side Effects Report #5254280-3
ALKERAN problem was reported by a Consumer or non-health professional from FRANCE on Feb 19, 2007. Male patient, 61 years of age, was diagnosed with multiple myeloma and was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: acidosis, bone marrow failure, bronchial obstruction, cardiac failure, confusional state, dyspnoea, hypercapnia, hypoxia, inflammation, . ALKERAN dosage: unknown. During the same period patient was treated with DEXAMETHASONE, HEMODIALYSIS. Patient was hospitalized. Patient died.